Abraxane and Diovan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abraxane (paclitaxel) and Diovan (valsartan). Common drug interactions include mucosal inflammation among females and jaundice among males.

The phase IV clinical study analyzes what interactions people have when they take Abraxane and Diovan. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Abraxane?

Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.

What is Diovan?

Diovan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 83,154 Diovan users. Check the latest studies of Diovan.

On Aug, 01, 2026

47 people who take Abraxane and Diovan together, and have interactions are studied.

What are the common drug interactions of Abraxane and Diovan, by gender? *:

female:

Mucosal inflammation (infection of mucous membrane)
Muscular weakness (muscle weakness)
Neck pain
Neoplasm progression (growth of tumour)
Oropharyngeal pain
Pain in extremity
Pulmonary oedema (fluid accumulation in the lungs)
Rash
Rash pruritic (redness with itching)
Respiratory failure (inadequate gas exchange by the respiratory system)

male:

Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Interstitial lung disease
Fall
Adverse drug reaction
Atelectasis (partial or complete collapse of the lung)
Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
Dehydration (dryness resulting from the removal of water)
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pancreatitis (inflammation of pancreas)

What are the common drug interactions of Abraxane and Diovan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anxiety
Constipation
Hepatic haematoma (collection of blood outside of blood vessels in liver)
Malignant neoplasm progression (cancer tumour came back)
Mucosal inflammation (infection of mucous membrane)
Pain
Dry eye (lack of adequate tears)
Large intestinal haemorrhage (bleeding in large intestine)
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)

50-59:

Febrile neutropenia (fever with reduced white blood cells)
Hyperkalaemia (damage to or disease of the kidney)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Hypotension (abnormally low blood pressure)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
Pulmonary embolism (blockage of the main artery of the lung)
Pyrexia (fever)
White blood cell count decreased
Completed suicide (act of taking one's own life)

60+:

Vomiting
Neuropathy peripheral (surface nerve damage)
Pyrexia (fever)
Nausea (feeling of having an urge to vomit)
Sepsis (a severe blood infection that can lead to organ failure and death)
Cardiac failure
Forearm fracture (fracture in between wrist to elbow)
Pericardial effusion (fluid around the heart)
Chest pain
Dehydration (dryness resulting from the removal of water)

What are the existing conditions these people have? *

Insomnia (sleeplessness): 12 people, 25.53%
Constipation: 10 people, 21.28%
Nausea (feeling of having an urge to vomit): 7 people, 14.89%
Pancreatic Carcinoma (pancreatic cancer): 5 people, 10.64%
Breast Cancer: 5 people, 10.64%
Indigestion: 5 people, 10.64%
Non-Small Cell Lung Cancer Stage Iv: 4 people, 8.51%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 8.51%
Itching: 4 people, 8.51%
Cough: 4 people, 8.51%

* Approximation only. Some reports may have incomplete information.

Do you take Abraxane and Diovan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously